Searched for
COMPULSORY LICENSES INDIA
Critical Stage: India's concert boom has a venue problemIndia's booming live entertainment scene, evidenced by massive ticket sales for global and local artists, faces a critical hurdle: a severe...
India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
Saregama doubles down on premium music IP even as it eyes AI monetisationSaregama is embracing an AI-driven future. The music label is exploring licensing deals with generative AI platforms. Simultaneously, it is...
India’s silver market faces purity crisis amid soaring investment demandCounterfeiters are flooding the Indian market with impure silver, exploiting rising prices and demand. Refiners are urging mandatory hallma...
Is there a curfew in Pune today? Here's what police said amid social media claimsPune Police have clarified that no city-wide curfew is in effect, debunking social media rumors of a 14-day lockdown. Officials stated that...
Gujarat saunf adulteration: 3,500 kg of fennel seeds dyed with unsafe chemicals seized in major raidThe Gujarat Food Safety Department seized more than 3,500 kilograms of allegedly adulterated fennel seeds from Ganapati Cleaning Factory in...
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRIIndia is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual prop...
India-UK trade pact not to restrict India's use of compulsory licensing in any form: MoS Jitin PrasadaIndia's ability to use compulsory licensing remains unrestricted by the India-UK free trade agreement. This vital tool for accessing life-s...
India-UK FTA does not dilute New Delhi's right to issue compulsory licences: OfficialAn official clarified that the India-UK free trade agreement doesn't weaken India's power to issue compulsory licenses or add new requireme...
India-UK trade pact subtly curtails India's ability to issue compulsory licenses: GTRIIndia's free trade agreement with the UK includes clauses on intellectual property. These clauses may limit India's ability to issue compul...
Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...
Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt“Introduction of the competition is the best way to lower the prices. Patent protection is the major barrier to the generic production of t...
Civil society petition in SC for compulsory licence for vaccine, key Covid drugs“Covid-19 is a public health emergency and the government is obligated to issue an order of government authorisation under Section 100 or a...
India 'privately' against patent-overriding drug permits: USIBCA compulsory license can be invoked by a national government to allow someone else to produce a patented product or process without the con...
IP environment deteriorating in India: US pharma industryUS pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights are unr...
- India lawyers bag Antitrust Writing Award
Two young Indian lawyers today bagged the prestigious Antitrust Writing Award for their article on "compulsary licensing in India".
Linking patented drug price to per capita income may hit generic drug makers: ExpertsA government panel's proposal to link the price of patented drugs to per capita income is likely to shut out the option of compulsory licen...
- Natco examining other drugs to identify compulsory license targets
We have mostly targeted unaffordable life saving drugs which are either unavailable or in-adequately available at an exorbitant cost. These...
- Pharma industry split over nod to Natco to sell Bayer's cancer drug
The decision to allow Natco Pharma to sell Bayer's patented cancer drug Nexavar has divided the pharmaceutical industry.
- ET in the classroom: Compulsory licencing
ET explains Compulsory Licensing, a provision that allows governments to override Patent rights